NCT00575562 2024-04-29Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal CancerKyowa Kirin Co., Ltd.Phase 1 Completed42 enrolled
NCT00838578 2024-04-26Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerKyowa Kirin Co., Ltd.Phase 1/2 Terminated65 enrolled 7 charts